JP2006508977A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508977A5
JP2006508977A5 JP2004553037A JP2004553037A JP2006508977A5 JP 2006508977 A5 JP2006508977 A5 JP 2006508977A5 JP 2004553037 A JP2004553037 A JP 2004553037A JP 2004553037 A JP2004553037 A JP 2004553037A JP 2006508977 A5 JP2006508977 A5 JP 2006508977A5
Authority
JP
Japan
Prior art keywords
palonosetron
pharmaceutical composition
vomiting
pharmaceutically acceptable
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004553037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508977A (ja
JP5690461B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/005567 external-priority patent/WO2004045615A1/en
Publication of JP2006508977A publication Critical patent/JP2006508977A/ja
Publication of JP2006508977A5 publication Critical patent/JP2006508977A5/ja
Application granted granted Critical
Publication of JP5690461B2 publication Critical patent/JP5690461B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004553037A 2002-11-15 2003-11-06 化学療法誘導嘔吐を治療するためのパロノセトロン Expired - Lifetime JP5690461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42682902P 2002-11-15 2002-11-15
US60/426,829 2002-11-15
PCT/IB2003/005567 WO2004045615A1 (en) 2002-11-15 2003-11-06 Palonosetron for the treatment of chemotherapy-induced emesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012034259A Division JP5893950B2 (ja) 2002-11-15 2012-02-20 化学療法誘導嘔吐を治療するためのパロノセトロン

Publications (3)

Publication Number Publication Date
JP2006508977A JP2006508977A (ja) 2006-03-16
JP2006508977A5 true JP2006508977A5 (enExample) 2006-12-21
JP5690461B2 JP5690461B2 (ja) 2015-03-25

Family

ID=32326433

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2004553037A Expired - Lifetime JP5690461B2 (ja) 2002-11-15 2003-11-06 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2012034259A Expired - Lifetime JP5893950B2 (ja) 2002-11-15 2012-02-20 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2015086840A Pending JP2015143266A (ja) 2002-11-15 2015-04-21 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2016162972A Expired - Lifetime JP6342960B2 (ja) 2002-11-15 2016-08-23 化学療法誘導嘔吐を治療するためのパロノセトロン

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012034259A Expired - Lifetime JP5893950B2 (ja) 2002-11-15 2012-02-20 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2015086840A Pending JP2015143266A (ja) 2002-11-15 2015-04-21 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2016162972A Expired - Lifetime JP6342960B2 (ja) 2002-11-15 2016-08-23 化学療法誘導嘔吐を治療するためのパロノセトロン

Country Status (6)

Country Link
US (2) US20060079545A1 (enExample)
JP (4) JP5690461B2 (enExample)
AU (1) AU2003302072A1 (enExample)
CA (1) CA2505990C (enExample)
DE (1) DE10393729T5 (enExample)
WO (1) WO2004045615A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303956A1 (en) * 2002-11-05 2004-11-23 Smithkline Beecham Corporation Antibacterial agents
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
EA016455B1 (ru) * 2006-10-24 2012-05-30 Хелсинн Хелткэр С.А. Мягкие капсулы, содержащие палоносетрона гидрохлорид, имеющие улучшенную стабильность и биологическую доступность
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
US20110118189A1 (en) * 2008-04-28 2011-05-19 Farr Stephen J Novel formulations for treatment of migraine
JP5547065B2 (ja) 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US20100048607A1 (en) * 2008-08-25 2010-02-25 Chandrashekhar Kocherlakota Formulations comprising palonosetron
EP2364138A2 (en) * 2008-12-08 2011-09-14 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
EP2499137A1 (en) 2009-11-13 2012-09-19 Helsinn Healthcare S.A. Palonosetron metabolites
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
PE20121483A1 (es) 2009-11-18 2012-12-02 Helsinn Healthcare Sa Composiciones para tratar nausea y vomito centralmente mediados
US20160206610A1 (en) * 2015-01-20 2016-07-21 Xoc Pharmaceuticals, Inc. Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesis
JP6642377B2 (ja) * 2016-10-25 2020-02-05 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US807381A (en) * 1905-01-10 1905-12-12 Auto Stopper Company Means for securing stoppers for vessels in their caps.
US1796729A (en) * 1930-04-18 1931-03-17 Aluminum Co Of America Closure
US2069075A (en) * 1934-04-20 1937-01-26 United Dairies London Ltd Bottle or like container
US2113176A (en) * 1936-03-26 1938-04-05 Guardian Safety Seal Company Sealed receptacle
US3314564A (en) * 1965-05-06 1967-04-18 West Co Container closure
US3601273A (en) * 1969-01-31 1971-08-24 Aluminum Co Of America Pilferproof closure with vertical weakening lines
DE2315962A1 (de) * 1972-04-05 1973-10-18 Metal Closures Ltd Verschlusskappenrohling fuer flaschen od. dgl.
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US5240954A (en) * 1985-06-25 1993-08-31 Glaxo Group Limited Medicaments
US4906755A (en) * 1986-11-03 1990-03-06 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
AU642178B2 (en) * 1989-11-28 1993-10-14 Roche Palo Alto Llc New tricyclic compounds
GB2277749B (en) * 1993-05-08 1996-12-04 Ciba Geigy Ag Fluorescent whitening of paper
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6294548B1 (en) * 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
US20030127420A1 (en) * 2002-01-09 2003-07-10 Klaus Schumacher Dual bottle closure
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride

Similar Documents

Publication Publication Date Title
JP2009525343A5 (enExample)
KR101113084B1 (ko) 파론노세트론의 액체 약제학적 제제
JP2013511507A5 (enExample)
HRP20140759T1 (hr) Kompozicije za lijeäśenje središnje posredovane muäśnine i povraä†anja
JP2011511072A5 (enExample)
JP2007515469A5 (enExample)
JP2016539156A5 (enExample)
JPH06502854A (ja) 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
JP2006513184A5 (enExample)
JP2014533277A5 (enExample)
JP2006514681A5 (enExample)
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
MX2011002177A (es) Metodo para combatir efectos adversos que surgen del tratamiento antipsicotico.
IL310909A (en) Dosing regimens associated with extended release paliperidone injectable formulations
US9066980B2 (en) Liquid pharmaceutical formulations of palonosetron
AU2006269628B2 (en) Pharmaceutical formulations of endo-N-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
JP2014502608A5 (enExample)
JP2005529152A5 (enExample)
JPH0455173B2 (enExample)
CO5271647A1 (es) Metodo para prevenir la diarrea
JP2007522202A5 (enExample)
RU2006119451A (ru) Cci-79 для лечения лимфомы из мантийных клеток
CN111110678A (zh) 一种含克唑替尼与山奈酚药物组合物及其应用
CN103239444A (zh) 右旋吲哚布芬与氯吡格雷的复方药物组合物
RU2013124994A (ru) КОМБИНАЦИЯ БЕВАЦИЗУМАБА И 2,2-ДИМЕТИЛ-N-((S)-6-ОКСО-6,7-ДИГИДРО-5Н-ДИБЕНЗО[b,d]АЗЕПИН-7-ИЛ)-N'-(2,2,3,3,3-ПЕНТАФТОР-ПРОПИЛ)-МАЛОНАМИДА ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ